Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Stock Short Interest Declines 89.7%

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) was the recipient of a large decline in short interest in October. As of October 30th, there was short interest totaling 138,641 shares, a decline of 89.7% from the October 15th total of 1,348,635 shares. Based on an average daily trading volume, of 269,329 shares, the short-interest ratio is currently 0.5 days. Approximately 0.0% of the company’s stock are sold short.

Wall Street Analyst Weigh In

Separately, Barclays upgraded shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, November 3rd. Two analysts have rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

Get Our Latest Report on Coloplast A/S

Coloplast A/S Stock Down 1.1%

CLPBY stock opened at $7.28 on Friday. The business has a 50 day moving average of $6.87 and a 200 day moving average of $6.76. The firm has a market cap of $16.41 billion, a PE ratio of 18.87, a price-to-earnings-growth ratio of 3.58 and a beta of 0.10. Coloplast A/S has a twelve month low of $5.64 and a twelve month high of $9.46. The company has a quick ratio of 0.94, a current ratio of 1.56 and a debt-to-equity ratio of 1.51.

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09. Coloplast A/S had a return on equity of 42.25% and a net margin of 10.57%. The business had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.12 billion. On average, research analysts forecast that Coloplast A/S will post 0.37 EPS for the current fiscal year.

About Coloplast A/S

(Get Free Report)

Coloplast A/S is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care. Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.

Featured Stories

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.